Shares of Eli Lilly & Co. LLY slid 4.73% to $869.58 Friday, on what proved to be an all-around positive trading session for ...

Eli Lilly (NYSE:LLY) saw a notable 10% increase in its stock price over the last month, driven by several important events.

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2024 investor ...

Whatever you think of Donald Trump’s tariff policies, one fact stands out: companies are looking to invest more in the United ...

There is currently a strange paradox in the world of pharmaceutical shares, despite the sector’s well-known status as a safe haven. The performance gap between the S&P 500 index and US pharmaceutical ...

Stock futures are little changed Wednesday night after the major averages rebounded on hopes for concessions on President ...

A slew of tech names tumbled in after-hours trading. Marvell Technology dropped more than 13% after posting narrow beats in ...

The S&P 500 was down slightly year to date before last Friday's rally, which boosted the index into positive territory.

Eli Lilly remains a favorite among billionaires, ranking 11th in top stock picks. The pharmaceutical giant’s 2024 revenue ...

Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...

The stock's fall snapped a two-day winning streak.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...